Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma
Zhao Tang(Nanjing Traditional Chinese Medicine Hospital), Helen C. Nauts(Cancer Research Institute), Li Chai(Harvard University), Ming Zhou(Guangzhou Medical University Cancer Hospital), Gang Zhao(Nebraska Medical Center), Kang Da Liu(Shanghai Medical College of Fudan University), Hai Zhou(Yuncheng University), Ji Zhen Lu(Shanghai Medical College of Fudan University), H. Francis Havas(Temple University)
Cited by 23
Related Papers
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
|JAMA|2024|359
ZNF143 mediates CTCF-bound promoter–enhancer loops required for murine hematopoietic stem and progenitor cell function
|Nature Communications|2021|90
Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C)
|The American Journal of Gastroenterology|2020|78
miR‐152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines
|The Prostate|2013|76
miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells
|Molecular and Cellular Biochemistry|2013|69